APO Research
Talk to an analyst

APO RESEARCH · REPORT

Cognitive Decline

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Cognitive Decline Market Outlook and Growth Opportunities 2026

30 December 2025212 pages

Choose your research edition.

Industry ResearchCognitive Decline Industry Research Report 2026141 pages · $2,950 USDIndustry Growth & TrendsGlobal Cognitive Decline Industry Growth and Trends Forecast to 2032123 pages · $3,450 USDMarket StructureGlobal Cognitive Decline Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cognitive Decline Market Outlook and Growth Opportunities 2026212 pages · $4,250 USDMarket Analysis & ForecastGlobal Cognitive Decline Market Analysis and Forecast 2026-2032211 pages · $4,950 USD

Market perspective

The global Cognitive Decline market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Cognitive Decline is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Cognitive Decline is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Cognitive Decline is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Cognitive Decline market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Cognitive Decline market include Stryker, TrueKAST (Wound Kair Concepts), Thuasne SAS, Talley Group Limited, Smith & Nephew, PROMA REHA, s. r. o., Paramount Bed Holdings Co., Ltd., ORTHOSERVICE AG and Mölnlycke Health Care, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Cognitive Decline market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Cognitive Decline and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Cognitive Decline revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Cognitive Decline market.

Cognitive Decline Segment by Company

Stryker

TrueKAST (Wound Kair Concepts)

Thuasne SAS

Talley Group Limited

Smith & Nephew

PROMA REHA, s. r. o.

Paramount Bed Holdings Co., Ltd.

ORTHOSERVICE AG

Mölnlycke Health Care

Medtronic

Medline Industries Inc.

Linet spol. S R.O.

Invacare Corporation

Hollister Incorporated

Hill-Rom Services Inc.

Drive DeVilbiss Healthcare Ltd (Sidhil Limited)

DJO Global

DeRoyal Industries

DARCO International

ConvaTec Group plc

Coloplast A/S

BSN Medical (Essity)

Breg, Inc.

ArjoHuntleigh

Apex Medical Corp.

ALGEOS

Advanced Orthopaedics

Cognitive Decline Segment by Type

by Drug Therapy

by Non-Invasive Stimulation Devices

Cognitive Decline Segment by Application

Mild Cognitive Impairment (MCI)

Dementia

Cognitive Decline Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Cognitive Decline status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Cognitive Decline key companies, revenue, market share, and recent developments.

3. To split the Cognitive Decline breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Cognitive Decline market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Cognitive Decline significant trends, drivers, influence factors in global and regions.

6. To analyze Cognitive Decline competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cognitive Decline market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cognitive Decline and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cognitive Decline.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Cognitive Decline industry.

Chapter 3: Detailed analysis of Cognitive Decline company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Cognitive Decline in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Cognitive Decline in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Cognitive Decline Industry Trends Table 2. Cognitive Decline Industry Drivers Table 3. Cognitive Decline Industry Opportunities and Challenges Table 4. Cognitive Decline Industry Restraints Table 5. Global Cognitive Decline Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Cognitive Decline Revenue Share by Company (2021-2026) Table 7. Global Cognitive Decline Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Cognitive Decline Key Company Manufacturing Base & Headquarters Table 9. Global Cognitive Decline Company, Product Type & Application Table 10. Global Cognitive Decline Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Cognitive Decline by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Type One Table 15. Significant Companies of Type Two Table 16. Global Cognitive Decline Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Cognitive Decline Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Cognitive Decline Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Cognitive Decline Sales Value Share by Type (2021-2026) Table 20. Global Cognitive Decline Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Mild Cognitive Impairment (MCI) Table 22. Significant Companies of Dementia Table 23. Global Cognitive Decline Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 24. Global Cognitive Decline Sales Value by Application (2021-2026) & (US$ Million) Table 25. Global Cognitive Decline Sales Value by Application (2027-2032) & (US$ Million) Table 26. Global Cognitive Decline Sales Value Share by Application (2021-2026) Table 27. Global Cognitive Decline Sales Value Share by Application (2027-2032) Table 28. Global Cognitive Decline Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Cognitive Decline Sales Value by Region (2021-2026) & (US$ Million) Table 30. Global Cognitive Decline Sales Value Share by Region (2021-2026) Table 31. Global Cognitive Decline Sales Value by Region (2027-2032) & (US$ Million) Table 32. Global Cognitive Decline Sales Value Share by Region (2027-2032) Table 33. Global Cognitive Decline Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Cognitive Decline Sales Value by Country (2021-2026) & (US$ Million) Table 35. Global Cognitive Decline Sales Value Market Share by Country (2021-2026) Table 36. Global Cognitive Decline Sales Value by Country (2027-2032) & (US$ Million) Table 37. Global Cognitive Decline Sales Value Market Share by Country (2027-2032) Table 38. Stryker Company Information Table 39. Stryker Business Overview Table 40. Stryker Cognitive Decline Revenue (US$ Million) and Gross Margin (2021-2026) Table 41. Stryker Cognitive Decline Product Portfolio Table 42. Stryker Recent Development Table 43. TrueKAST (Wound Kair Concepts) Company Information Table 44. TrueKAST (Wound Kair Concepts) Business Overview Table 45. TrueKAST (Wound Kair Concepts) Cognitive Decline Revenue (US$ Million) and Gross Margin (2021-2026) Table 46. TrueKAST (Wound Kair Concepts) Cognitive Decline Product Portfolio Table 47. TrueKAST (Wound Kair Concepts) Recent Development Table 48. Thuasne SAS Company Information Table 49. Thuasne SAS Business Overview Table 50. Thuasne SAS Cognitive Decline Revenue (US$ Million) and Gross Margin (2021-2026) Table 51. Thuasne SAS Cognitive Decline Product Portfolio Table 52. Thuasne SAS Recent Development Table 53. Talley Group Limited Company Information Table 54. Talley Group Limited Business Overview Table 55. Talley Group Limited Cognitive Decline Revenue (US$ Million) and Gross Margin (2021-2026) Table 56. Talley Group Limited Cognitive Decline Product Portfolio Table 57. Talley Group Limited Recent Development Table 58. Smith & Nephew Company Information Table 59. Smith & Nephew Business Overview Table 60. Smith & Nephew Cognitive Decline Revenue (US$ Million) and Gross Margin (2021-2026) Table 61. Smith & Nephew Cognitive Decline Product Portfolio Table 62. Smith & Nephew Recent Development Table 63. PROMA REHA, s. r. o. Company Information Table 64. PROMA REHA, s. r. o. Business Overview Table 65. PROMA REHA, s. r. o. Cognitive Decline Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. PROMA REHA, s. r. o. Cognitive Decline Product Portfolio Table 67. PROMA REHA, s. r. o. Recent Development Table 68. Paramount Bed Holdings Co., Ltd. Company Information Table 69. Paramount Bed Holdings Co., Ltd. Business Overview Table 70. Paramount Bed Holdings Co., Ltd. Cognitive Decline Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Paramount Bed Holdings Co., Ltd. Cognitive Decline Product Portfolio Table 72. Paramount Bed Holdings Co., Ltd. Recent Development Table 73. ORTHOSERVICE AG Company Information Table 74. ORTHOSERVICE AG Business Overview Table 75. ORTHOSERVICE AG Cognitive Decline Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. ORTHOSERVICE AG Cognitive Decline Product Portfolio Table 77. ORTHOSERVICE AG Recent Development Table 78. Mölnlycke Health Care Company Information Table 79. Mölnlycke Health Care Business Overview Table 80. Mölnlycke Health Care Cognitive Decline Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Mölnlycke Health Care Cognitive Decline Product Portfolio Table 82. Mölnlycke Health Care Recent Development Table 83. Medtronic Company Information Table 84. Medtronic Business Overview Table 85. Medtronic Cognitive Decline Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Medtronic Cognitive Decline Product Portfolio Table 87. Medtronic Recent Development Table 88. Medline Industries Inc. Company Information Table 89. Medline Industries Inc. Business Overview Table 90. Medline Industries Inc. Cognitive Decline Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Medline Industries Inc. Cognitive Decline Product Portfolio Table 92. Medline Industries Inc. Recent Development Table 93. Linet spol. S R.O. Company Information Table 94. Linet spol. S R.O. Business Overview Table 95. Linet spol. S R.O. Cognitive Decline Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Linet spol. S R.O. Cognitive Decline Product Portfolio Table 97. Linet spol. S R.O. Recent Development Table 98. Invacare Corporation Company Information Table 99. Invacare Corporation Business Overview Table 100. Invacare Corporation Cognitive Decline Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Invacare Corporation Cognitive Decline Product Portfolio Table 102. Invacare Corporation Recent Development Table 103. Hollister Incorporated Company Information Table 104. Hollister Incorporated Business Overview Table 105. Hollister Incorporated Cognitive Decline Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Hollister Incorporated Cognitive Decline Product Portfolio Table 107. Hollister Incorporated Recent Development Table 108. Hill-Rom Services Inc. Company Information Table 109. Hill-Rom Services Inc. Business Overview Table 110. Hill-Rom Services Inc. Cognitive Decline Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Hill-Rom Services Inc. Cognitive Decline Product Portfolio Table 112. Hill-Rom Services Inc. Recent Development Table 113. Drive DeVilbiss Healthcare Ltd (Sidhil Limited) Company Information Table 114. Drive DeVilbiss Healthcare Ltd (Sidhil Limited) Business Overview Table 115. Drive DeVilbiss Healthcare Ltd (Sidhil Limited) Cognitive Decline Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. Drive DeVilbiss Healthcare Ltd (Sidhil Limited) Cognitive Decline Product Portfolio Table 117. Drive DeVilbiss Healthcare Ltd (Sidhil Limited) Recent Development Table 118. DJO Global Company Information Table 119. DJO Global Business Overview Table 120. DJO Global Cognitive Decline Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 121. DJO Global Cognitive Decline Product Portfolio Table 122. DJO Global Recent Development Table 123. DeRoyal Industries Company Information Table 124. DeRoyal Industries Business Overview Table 125. DeRoyal Industries Cognitive Decline Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 126. DeRoyal Industries Cognitive Decline Product Portfolio Table 127. DeRoyal Industries Recent Development Table 128. DARCO International Company Information Table 129. DARCO International Business Overview Table 130. DARCO International Cognitive Decline Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 131. DARCO International Cognitive Decline Product Portfolio Table 132. DARCO International Recent Development Table 133. ConvaTec Group plc Company Information Table 134. ConvaTec Group plc Business Overview Table 135. ConvaTec Group plc Cognitive Decline Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 136. ConvaTec Group plc Cognitive Decline Product Portfolio Table 137. ConvaTec Group plc Recent Development Table 138. Coloplast A/S Company Information Table 139. Coloplast A/S Business Overview Table 140. Coloplast A/S Cognitive Decline Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 141. Coloplast A/S Cognitive Decline Product Portfolio Table 142. Coloplast A/S Recent Development Table 143. BSN Medical (Essity) Company Information Table 144. BSN Medical (Essity) Business Overview Table 145. BSN Medical (Essity) Cognitive Decline Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 146. BSN Medical (Essity) Cognitive Decline Product Portfolio Table 147. BSN Medical (Essity) Recent Development Table 148. Breg, Inc. Company Information Table 149. Breg, Inc. Business Overview Table 150. Breg, Inc. Cognitive Decline Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 151. Breg, Inc. Cognitive Decline Product Portfolio Table 152. Breg, Inc. Recent Development Table 153. ArjoHuntleigh Company Information Table 154. ArjoHuntleigh Business Overview Table 155. ArjoHuntleigh Cognitive Decline Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 156. ArjoHuntleigh Cognitive Decline Product Portfolio Table 157. ArjoHuntleigh Recent Development Table 158. Apex Medical Corp. Company Information Table 159. Apex Medical Corp. Business Overview Table 160. Apex Medical Corp. Cognitive Decline Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 161. Apex Medical Corp. Cognitive Decline Product Portfolio Table 162. Apex Medical Corp. Recent Development Table 163. ALGEOS Company Information Table 164. ALGEOS Business Overview Table 165. ALGEOS Cognitive Decline Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 166. ALGEOS Cognitive Decline Product Portfolio Table 167. ALGEOS Recent Development Table 168. Advanced Orthopaedics Company Information Table 169. Advanced Orthopaedics Business Overview Table 170. Advanced Orthopaedics Cognitive Decline Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 171. Advanced Orthopaedics Cognitive Decline Product Portfolio Table 172. Advanced Orthopaedics Recent Development Table 173. Research Programs/Design for This Report Table 174. Authors List of This Report Table 175. Secondary Sources Table 176. Primary Sources List of Figures Figure 1. Cognitive Decline Product Image Figure 2. Global Cognitive Decline Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Cognitive Decline Market Size (2021-2032) & (US$ Million) Figure 4. Global Cognitive Decline Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Type I Image Figure 8. Type II Image Figure 9. Global Cognitive Decline Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Cognitive Decline Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Cognitive Decline Sales Value Share by Type (2021-2032) Figure 12. Mild Cognitive Impairment (MCI) Image Figure 13. Dementia Image Figure 14. Global Cognitive Decline Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Cognitive Decline Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Cognitive Decline Sales Value Share by Application (2021-2032) Figure 17. Global Cognitive Decline Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 18. Global Cognitive Decline Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 19. North America Cognitive Decline Sales Value (2021-2032) & (US$ Million) Figure 20. North America Cognitive Decline Sales Value Share by Country (%), 2025 VS 2032 Figure 21. Europe Cognitive Decline Sales Value (2021-2032) & (US$ Million) Figure 22. Europe Cognitive Decline Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Asia-Pacific Cognitive Decline Sales Value (2021-2032) & (US$ Million) Figure 24. Asia-Pacific Cognitive Decline Sales Value Share by Country (%), 2025 VS 2032 Figure 25. South America Cognitive Decline Sales Value (2021-2032) & (US$ Million) Figure 26. South America Cognitive Decline Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Middle East & Africa Cognitive Decline Sales Value (2021-2032) & (US$ Million) Figure 28. Middle East & Africa Cognitive Decline Sales Value Share by Country (%), 2025 VS 2032 Figure 29. USA Cognitive Decline Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 30. USA Cognitive Decline Sales Value Share by Type, 2025 VS 2032 & (%) Figure 31. USA Cognitive Decline Sales Value Share by Application, 2025 VS 2032 & (%) Figure 32. Canada Cognitive Decline Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. Canada Cognitive Decline Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. Canada Cognitive Decline Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Mexico Cognitive Decline Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Mexico Cognitive Decline Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Mexico Cognitive Decline Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Germany Cognitive Decline Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Germany Cognitive Decline Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Germany Cognitive Decline Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. France Cognitive Decline Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. France Cognitive Decline Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. France Cognitive Decline Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. U.K. Cognitive Decline Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. U.K. Cognitive Decline Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. U.K. Cognitive Decline Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Italy Cognitive Decline Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Italy Cognitive Decline Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Italy Cognitive Decline Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Spain Cognitive Decline Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Spain Cognitive Decline Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Spain Cognitive Decline Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Russia Cognitive Decline Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Russia Cognitive Decline Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Russia Cognitive Decline Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Netherlands Cognitive Decline Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Netherlands Cognitive Decline Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Netherlands Cognitive Decline Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Nordic Countries Cognitive Decline Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Nordic Countries Cognitive Decline Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Nordic Countries Cognitive Decline Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. China Cognitive Decline Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. China Cognitive Decline Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. China Cognitive Decline Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Japan Cognitive Decline Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Japan Cognitive Decline Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Japan Cognitive Decline Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. South Korea Cognitive Decline Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. South Korea Cognitive Decline Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. South Korea Cognitive Decline Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. India Cognitive Decline Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. India Cognitive Decline Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. India Cognitive Decline Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. Australia Cognitive Decline Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. Australia Cognitive Decline Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. Australia Cognitive Decline Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Southeast Asia Cognitive Decline Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Southeast Asia Cognitive Decline Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Southeast Asia Cognitive Decline Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Brazil Cognitive Decline Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Brazil Cognitive Decline Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Brazil Cognitive Decline Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Argentina Cognitive Decline Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Argentina Cognitive Decline Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Argentina Cognitive Decline Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Chile Cognitive Decline Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Chile Cognitive Decline Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Chile Cognitive Decline Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Colombia Cognitive Decline Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Colombia Cognitive Decline Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Colombia Cognitive Decline Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Peru Cognitive Decline Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Peru Cognitive Decline Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Peru Cognitive Decline Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Saudi Arabia Cognitive Decline Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Saudi Arabia Cognitive Decline Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Cognitive Decline Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Israel Cognitive Decline Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Israel Cognitive Decline Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Israel Cognitive Decline Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. UAE Cognitive Decline Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. UAE Cognitive Decline Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. UAE Cognitive Decline Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Turkey Cognitive Decline Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Turkey Cognitive Decline Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Turkey Cognitive Decline Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Iran Cognitive Decline Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Iran Cognitive Decline Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Iran Cognitive Decline Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Egypt Cognitive Decline Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Egypt Cognitive Decline Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Egypt Cognitive Decline Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Years Considered Figure 114. Research Process Figure 115. Key Executives Interviewed

Scope & coverage.

Applications
  • Mild Cognitive Impairment (MCI)
  • Dementia
Companies covered
  • Stryker
  • TrueKAST (Wound Kair Concepts)
  • Thuasne SAS
  • Talley Group Limited
  • Smith & Nephew
  • PROMA REHA, s. r. o.
  • Paramount Bed Holdings Co., Ltd.
  • ORTHOSERVICE AG
  • Mölnlycke Health Care
  • Medtronic
  • Medline Industries Inc.
  • Linet spol. S R.O.
  • Invacare Corporation
  • Hollister Incorporated
  • Hill-Rom Services Inc.
  • Drive DeVilbiss Healthcare Ltd (Sidhil Limited)
  • DJO Global
  • DeRoyal Industries
  • DARCO International
  • ConvaTec Group plc
  • Coloplast A/S
  • BSN Medical (Essity)
  • Breg, Inc.
  • ArjoHuntleigh
  • Apex Medical Corp.
  • ALGEOS
  • Advanced Orthopaedics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Cognitive Decline Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Cognitive Decline Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Cognitive Decline Market Dynamics
  1. 2.1 Cognitive Decline Industry Trends
  2. 2.2 Cognitive Decline Industry Drivers
  3. 2.3 Cognitive Decline Industry Opportunities and Challenges
  4. 2.4 Cognitive Decline Industry Restraints
3 Cognitive Decline Market by Company
  1. 3.1 Global Cognitive Decline Company Revenue Ranking in 2025
  2. 3.2 Global Cognitive Decline Revenue by Company (2021-2026)
  3. 3.3 Global Cognitive Decline Company Ranking (2024-2026)
  4. 3.4 Global Cognitive Decline Company Manufacturing Base and Headquarters
  5. 3.5 Global Cognitive Decline Company Product Type and Application
  6. 3.6 Global Cognitive Decline Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Cognitive Decline Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Cognitive Decline Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Cognitive Decline Market by Type
  1. 4.1 Cognitive Decline Type Introduction
  2. 4.1.1 by Drug Therapy
  3. 4.1.2 by Non-Invasive Stimulation Devices
  4. 4.2 Global Cognitive Decline Sales Value by Type
  5. 4.2.1 Global Cognitive Decline Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Cognitive Decline Sales Value by Type (2021-2032)
  7. 4.2.3 Global Cognitive Decline Sales Value Share by Type (2021-2032)
5 Cognitive Decline Market by Application
  1. 5.1 Cognitive Decline Application Introduction
  2. 5.1.1 Mild Cognitive Impairment (MCI)
  3. 5.1.2 Dementia
  4. 5.2 Global Cognitive Decline Sales Value by Application
  5. 5.2.1 Global Cognitive Decline Sales Value by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Cognitive Decline Sales Value by Application (2021-2032)
  7. 5.2.3 Global Cognitive Decline Sales Value Share by Application (2021-2032)
6 Cognitive Decline Regional Value Analysis
  1. 6.1 Global Cognitive Decline Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Cognitive Decline Sales Value by Region (2021-2032)
  3. 6.2.1 Global Cognitive Decline Sales Value by Region: 2021-2026
  4. 6.2.2 Global Cognitive Decline Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Cognitive Decline Sales Value (2021-2032)
  7. 6.3.2 North America Cognitive Decline Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Cognitive Decline Sales Value (2021-2032)
  10. 6.4.2 Europe Cognitive Decline Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Cognitive Decline Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Cognitive Decline Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Cognitive Decline Sales Value (2021-2032)
  16. 6.6.2 South America Cognitive Decline Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Cognitive Decline Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Cognitive Decline Sales Value Share by Country, 2025 VS 2032
7 Cognitive Decline Country-level Value Analysis
  1. 7.1 Global Cognitive Decline Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Cognitive Decline Sales Value by Country (2021-2032)
  3. 7.2.1 Global Cognitive Decline Sales Value by Country (2021-2026)
  4. 7.2.2 Global Cognitive Decline Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Cognitive Decline Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Cognitive Decline Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Cognitive Decline Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Cognitive Decline Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Cognitive Decline Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Cognitive Decline Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Cognitive Decline Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Cognitive Decline Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Cognitive Decline Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Cognitive Decline Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Cognitive Decline Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Cognitive Decline Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Cognitive Decline Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Cognitive Decline Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Cognitive Decline Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Cognitive Decline Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Cognitive Decline Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Cognitive Decline Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Cognitive Decline Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Cognitive Decline Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Cognitive Decline Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Cognitive Decline Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Cognitive Decline Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Cognitive Decline Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Cognitive Decline Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Cognitive Decline Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Cognitive Decline Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Cognitive Decline Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Cognitive Decline Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Cognitive Decline Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Cognitive Decline Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Cognitive Decline Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Cognitive Decline Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Cognitive Decline Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Cognitive Decline Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Cognitive Decline Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Cognitive Decline Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Cognitive Decline Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Cognitive Decline Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Cognitive Decline Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Cognitive Decline Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Cognitive Decline Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Cognitive Decline Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Cognitive Decline Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Cognitive Decline Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Cognitive Decline Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Cognitive Decline Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Cognitive Decline Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Cognitive Decline Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Cognitive Decline Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Cognitive Decline Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Cognitive Decline Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Cognitive Decline Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Cognitive Decline Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Cognitive Decline Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Cognitive Decline Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Cognitive Decline Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Cognitive Decline Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Cognitive Decline Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Cognitive Decline Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Cognitive Decline Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Cognitive Decline Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Cognitive Decline Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Cognitive Decline Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Cognitive Decline Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Cognitive Decline Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Cognitive Decline Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Cognitive Decline Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Cognitive Decline Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Cognitive Decline Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Cognitive Decline Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Cognitive Decline Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Cognitive Decline Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Cognitive Decline Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Cognitive Decline Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Cognitive Decline Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Cognitive Decline Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Cognitive Decline Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Cognitive Decline Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Cognitive Decline Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Cognitive Decline Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Cognitive Decline Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Cognitive Decline Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Cognitive Decline Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Stryker
  2. 8.1.1 Stryker Company Information
  3. 8.1.2 Stryker Business Overview
  4. 8.1.3 Stryker Cognitive Decline Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Stryker Cognitive Decline Product Portfolio
  6. 8.1.5 Stryker Recent Developments
  7. 8.2 TrueKAST (Wound Kair Concepts)
  8. 8.2.1 TrueKAST (Wound Kair Concepts) Company Information
  9. 8.2.2 TrueKAST (Wound Kair Concepts) Business Overview
  10. 8.2.3 TrueKAST (Wound Kair Concepts) Cognitive Decline Revenue and Gross Margin (2021-2026)
  11. 8.2.4 TrueKAST (Wound Kair Concepts) Cognitive Decline Product Portfolio
  12. 8.2.5 TrueKAST (Wound Kair Concepts) Recent Developments
  13. 8.3 Thuasne SAS
  14. 8.3.1 Thuasne SAS Company Information
  15. 8.3.2 Thuasne SAS Business Overview
  16. 8.3.3 Thuasne SAS Cognitive Decline Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Thuasne SAS Cognitive Decline Product Portfolio
  18. 8.3.5 Thuasne SAS Recent Developments
  19. 8.4 Talley Group Limited
  20. 8.4.1 Talley Group Limited Company Information
  21. 8.4.2 Talley Group Limited Business Overview
  22. 8.4.3 Talley Group Limited Cognitive Decline Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Talley Group Limited Cognitive Decline Product Portfolio
  24. 8.4.5 Talley Group Limited Recent Developments
  25. 8.5 Smith & Nephew
  26. 8.5.1 Smith & Nephew Company Information
  27. 8.5.2 Smith & Nephew Business Overview
  28. 8.5.3 Smith & Nephew Cognitive Decline Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Smith & Nephew Cognitive Decline Product Portfolio
  30. 8.5.5 Smith & Nephew Recent Developments
  31. 8.6 PROMA REHA, s. r. o.
  32. 8.6.1 PROMA REHA, s. r. o. Company Information
  33. 8.6.2 PROMA REHA, s. r. o. Business Overview
  34. 8.6.3 PROMA REHA, s. r. o. Cognitive Decline Revenue and Gross Margin (2021-2026)
  35. 8.6.4 PROMA REHA, s. r. o. Cognitive Decline Product Portfolio
  36. 8.6.5 PROMA REHA, s. r. o. Recent Developments
  37. 8.7 Paramount Bed Holdings Co., Ltd.
  38. 8.7.1 Paramount Bed Holdings Co., Ltd. Company Information
  39. 8.7.2 Paramount Bed Holdings Co., Ltd. Business Overview
  40. 8.7.3 Paramount Bed Holdings Co., Ltd. Cognitive Decline Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Paramount Bed Holdings Co., Ltd. Cognitive Decline Product Portfolio
  42. 8.7.5 Paramount Bed Holdings Co., Ltd. Recent Developments
  43. 8.8 ORTHOSERVICE AG
  44. 8.8.1 ORTHOSERVICE AG Company Information
  45. 8.8.2 ORTHOSERVICE AG Business Overview
  46. 8.8.3 ORTHOSERVICE AG Cognitive Decline Revenue and Gross Margin (2021-2026)
  47. 8.8.4 ORTHOSERVICE AG Cognitive Decline Product Portfolio
  48. 8.8.5 ORTHOSERVICE AG Recent Developments
  49. 8.9 Mölnlycke Health Care
  50. 8.9.1 Mölnlycke Health Care Company Information
  51. 8.9.2 Mölnlycke Health Care Business Overview
  52. 8.9.3 Mölnlycke Health Care Cognitive Decline Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Mölnlycke Health Care Cognitive Decline Product Portfolio
  54. 8.9.5 Mölnlycke Health Care Recent Developments
  55. 8.10 Medtronic
  56. 8.10.1 Medtronic Company Information
  57. 8.10.2 Medtronic Business Overview
  58. 8.10.3 Medtronic Cognitive Decline Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Medtronic Cognitive Decline Product Portfolio
  60. 8.10.5 Medtronic Recent Developments
  61. 8.11 Medline Industries Inc.
  62. 8.11.1 Medline Industries Inc. Company Information
  63. 8.11.2 Medline Industries Inc. Business Overview
  64. 8.11.3 Medline Industries Inc. Cognitive Decline Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Medline Industries Inc. Cognitive Decline Product Portfolio
  66. 8.11.5 Medline Industries Inc. Recent Developments
  67. 8.12 Linet spol. S R.O.
  68. 8.12.1 Linet spol. S R.O. Company Information
  69. 8.12.2 Linet spol. S R.O. Business Overview
  70. 8.12.3 Linet spol. S R.O. Cognitive Decline Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Linet spol. S R.O. Cognitive Decline Product Portfolio
  72. 8.12.5 Linet spol. S R.O. Recent Developments
  73. 8.13 Invacare Corporation
  74. 8.13.1 Invacare Corporation Company Information
  75. 8.13.2 Invacare Corporation Business Overview
  76. 8.13.3 Invacare Corporation Cognitive Decline Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Invacare Corporation Cognitive Decline Product Portfolio
  78. 8.13.5 Invacare Corporation Recent Developments
  79. 8.14 Hollister Incorporated
  80. 8.14.1 Hollister Incorporated Company Information
  81. 8.14.2 Hollister Incorporated Business Overview
  82. 8.14.3 Hollister Incorporated Cognitive Decline Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Hollister Incorporated Cognitive Decline Product Portfolio
  84. 8.14.5 Hollister Incorporated Recent Developments
  85. 8.15 Hill-Rom Services Inc.
  86. 8.15.1 Hill-Rom Services Inc. Company Information
  87. 8.15.2 Hill-Rom Services Inc. Business Overview
  88. 8.15.3 Hill-Rom Services Inc. Cognitive Decline Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Hill-Rom Services Inc. Cognitive Decline Product Portfolio
  90. 8.15.5 Hill-Rom Services Inc. Recent Developments
  91. 8.16 Drive DeVilbiss Healthcare Ltd (Sidhil Limited)
  92. 8.16.1 Drive DeVilbiss Healthcare Ltd (Sidhil Limited) Company Information
  93. 8.16.2 Drive DeVilbiss Healthcare Ltd (Sidhil Limited) Business Overview
  94. 8.16.3 Drive DeVilbiss Healthcare Ltd (Sidhil Limited) Cognitive Decline Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Drive DeVilbiss Healthcare Ltd (Sidhil Limited) Cognitive Decline Product Portfolio
  96. 8.16.5 Drive DeVilbiss Healthcare Ltd (Sidhil Limited) Recent Developments
  97. 8.17 DJO Global
  98. 8.17.1 DJO Global Company Information
  99. 8.17.2 DJO Global Business Overview
  100. 8.17.3 DJO Global Cognitive Decline Revenue and Gross Margin (2021-2026)
  101. 8.17.4 DJO Global Cognitive Decline Product Portfolio
  102. 8.17.5 DJO Global Recent Developments
  103. 8.18 DeRoyal Industries
  104. 8.18.1 DeRoyal Industries Company Information
  105. 8.18.2 DeRoyal Industries Business Overview
  106. 8.18.3 DeRoyal Industries Cognitive Decline Revenue and Gross Margin (2021-2026)
  107. 8.18.4 DeRoyal Industries Cognitive Decline Product Portfolio
  108. 8.18.5 DeRoyal Industries Recent Developments
  109. 8.19 DARCO International
  110. 8.19.1 DARCO International Company Information
  111. 8.19.2 DARCO International Business Overview
  112. 8.19.3 DARCO International Cognitive Decline Revenue and Gross Margin (2021-2026)
  113. 8.19.4 DARCO International Cognitive Decline Product Portfolio
  114. 8.19.5 DARCO International Recent Developments
  115. 8.20 ConvaTec Group plc
  116. 8.20.1 ConvaTec Group plc Company Information
  117. 8.20.2 ConvaTec Group plc Business Overview
  118. 8.20.3 ConvaTec Group plc Cognitive Decline Revenue and Gross Margin (2021-2026)
  119. 8.20.4 ConvaTec Group plc Cognitive Decline Product Portfolio
  120. 8.20.5 ConvaTec Group plc Recent Developments
  121. 8.21 Coloplast A/S
  122. 8.21.1 Coloplast A/S Company Information
  123. 8.21.2 Coloplast A/S Business Overview
  124. 8.21.3 Coloplast A/S Cognitive Decline Revenue and Gross Margin (2021-2026)
  125. 8.21.4 Coloplast A/S Cognitive Decline Product Portfolio
  126. 8.21.5 Coloplast A/S Recent Developments
  127. 8.22 BSN Medical (Essity)
  128. 8.22.1 BSN Medical (Essity) Company Information
  129. 8.22.2 BSN Medical (Essity) Business Overview
  130. 8.22.3 BSN Medical (Essity) Cognitive Decline Revenue and Gross Margin (2021-2026)
  131. 8.22.4 BSN Medical (Essity) Cognitive Decline Product Portfolio
  132. 8.22.5 BSN Medical (Essity) Recent Developments
  133. 8.23 Breg, Inc.
  134. 8.23.1 Breg, Inc. Company Information
  135. 8.23.2 Breg, Inc. Business Overview
  136. 8.23.3 Breg, Inc. Cognitive Decline Revenue and Gross Margin (2021-2026)
  137. 8.23.4 Breg, Inc. Cognitive Decline Product Portfolio
  138. 8.23.5 Breg, Inc. Recent Developments
  139. 8.24 ArjoHuntleigh
  140. 8.24.1 ArjoHuntleigh Company Information
  141. 8.24.2 ArjoHuntleigh Business Overview
  142. 8.24.3 ArjoHuntleigh Cognitive Decline Revenue and Gross Margin (2021-2026)
  143. 8.24.4 ArjoHuntleigh Cognitive Decline Product Portfolio
  144. 8.24.5 ArjoHuntleigh Recent Developments
  145. 8.25 Apex Medical Corp.
  146. 8.25.1 Apex Medical Corp. Company Information
  147. 8.25.2 Apex Medical Corp. Business Overview
  148. 8.25.3 Apex Medical Corp. Cognitive Decline Revenue and Gross Margin (2021-2026)
  149. 8.25.4 Apex Medical Corp. Cognitive Decline Product Portfolio
  150. 8.25.5 Apex Medical Corp. Recent Developments
  151. 8.26 ALGEOS
  152. 8.26.1 ALGEOS Company Information
  153. 8.26.2 ALGEOS Business Overview
  154. 8.26.3 ALGEOS Cognitive Decline Revenue and Gross Margin (2021-2026)
  155. 8.26.4 ALGEOS Cognitive Decline Product Portfolio
  156. 8.26.5 ALGEOS Recent Developments
  157. 8.27 Advanced Orthopaedics
  158. 8.27.1 Advanced Orthopaedics Company Information
  159. 8.27.2 Advanced Orthopaedics Business Overview
  160. 8.27.3 Advanced Orthopaedics Cognitive Decline Revenue and Gross Margin (2021-2026)
  161. 8.27.4 Advanced Orthopaedics Cognitive Decline Product Portfolio
  162. 8.27.5 Advanced Orthopaedics Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst